BioSpace News Archive

Valent BioSciences and Valent U.S.A. are collaborating with Halo to launch an open innovation initiative utilizing Halo’s state-of-the-art technology platform.

bioAffinity Technologies, a privately held biotech company, will present the Company’s discoveries in the field of cancer diagnostics and therapeutics at the RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium June 23 – 25, 2021, and the International Conference on Porphyrins and Phthalocyanines (ICPP) June 28 – July 3, 2021

The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic roll out programs.

Susan G. Komen®, the world’s leading breast cancer organization, announced the addition of six esteemed breast cancer researchers and three new patient advocates to important advisory roles.

The market is estimated to grow with a CAGR of 9.4% from 2020-2027.

The report highlights trends prevailing in the global dry eye product market, and the drivers and hindrances pertaining to the market growth.

The market is estimated to grow at a CAGR of 32.2% from 2020 to 2027.

The report highlights trends prevailing in the global mail order pharmacy market, and the drivers and restraints pertaining to the market growth.

The report highlights key driving factors and also the prominent players and their developments in the market.

PTC Therapeutics, Inc. announced that Evrysdi™ was approved in Japan by the Japanese Ministry of Health, Labor and Welfare for the treatment of spinal muscular atrophy.